While the SSAGA was developed prior to the publication of the DSM-IV criteria, all criteria symptoms for the DSM-IV diagnosis were assessed ages of onset and remission of symptoms [35 (link)]. Only the original probands or comparison subjects, their first-degree relatives, and offspring aged ≤20 years in the participating families were eligible for follow-up. Of all eligible subjects, the follow-up rate was 60% in probands, 65% in family members, and 78% in controls [35 (link)].
The interview also assessed past episodes of affective disorders, including depressive and manic episodes and the characteristics of the most severe episode. To receive a DSM-IV bipolar I disorder diagnosis, subjects had to report a lifetime diagnosis of both major depression and mania or any lifetime diagnosis of a manic episode. Individuals who had at least one major depression and hypomanic episode were considered to have bipolar II disorder.
N = 180 subjects with bipolar I or II disorder were identified. Of these n = 65 (36.1%) had an additional diagnosis of DSM IV CUD (cannabis dependence and cannabis abuse, CUD in 23 of 77 (29.8%) individuals, in bipolar II subjects and 40.8% (42 of 103 individuals in bipolar I subjects). Any CUDs (dependence and abuse) was found in 36.1% of bipolar I and II individuals.
Subjects with a bipolar II disorder without comorbid CUD but abstinent or with social CU were included into group 1 (n = 54) while group 2 (n = 23) consists of individuals with comorbid bipolar II and CUD diagnoses. Group 3 included subjects with a bipolar I diagnosis without CUD (n = 61) but either abstinence or social CU and group 4 were bipolar I subjects with a comorbid CUD (n = 42).
The probands and appropriate relatives were re-assessed at a mean of 5.72 years (±1.1 years) after the initial interview.